PD-L1 expression was noted in 18.9% (83/440) of ECs (Figure 1) and found to be significantly associated with Type II (non-endometrioid) histology (p = 0.0005) and lymph node metastasis (p = 0.0172). Here, CD274 is linked to metastatic malignant neoplasm in the lymph nodes.